138 related articles for article (PubMed ID: 17445651)
1. Obesity and benign prostatic enlargement: a large observational study in China.
Xie LP; Bai Y; Zhang XZ; Zheng XY; Yao KS; Xu L; Zeegers MP
Urology; 2007 Apr; 69(4):680-4. PubMed ID: 17445651
[TBL] [Abstract][Full Text] [Related]
2. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE.
Kane CJ; Bassett WW; Sadetsky N; Silva S; Wallace K; Pasta DJ; Cooperberg MR; Chan JM; Carroll PR
J Urol; 2005 Mar; 173(3):732-6. PubMed ID: 15711258
[TBL] [Abstract][Full Text] [Related]
3. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
[TBL] [Abstract][Full Text] [Related]
4. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Kristal AR; Arnold KB; Schenk JM; Neuhouser ML; Weiss N; Goodman P; Antvelink CM; Penson DF; Thompson IM
J Urol; 2007 Apr; 177(4):1395-400; quiz 1591. PubMed ID: 17382740
[TBL] [Abstract][Full Text] [Related]
5. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
6. [Relation between benign prostatic hyperplasia and obesity and estrogen].
Matsuda T; Abe H; Suda K
Rinsho Byori; 2004 Apr; 52(4):291-4. PubMed ID: 15164594
[TBL] [Abstract][Full Text] [Related]
7. Anthropometric and metabolic phenotypes in relation to the ADRA2B deletion/insertion polymorphism in Chinese population.
Li LH; Li Y; Wen Y; Wang JG
J Hypertens; 2008 Nov; 26(11):2161-7. PubMed ID: 18854756
[TBL] [Abstract][Full Text] [Related]
8. Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study.
Chia SE; Lau WK; Chin CM; Tan J; Ho SH; Lee J; Cheng C
BJU Int; 2009 Jun; 103(11):1487-91. PubMed ID: 19076145
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of erectile dysfunction among Brazilian men screened for prostate cancer.
Paranhos M; Antunes A; Andrade E; Freire G; Srougi M
BJU Int; 2009 Oct; 104(8):1130-3. PubMed ID: 19426190
[TBL] [Abstract][Full Text] [Related]
10. [Study on the relationship between body index and blood pressure in Chinese adult].
Wang Z; Zhai F; Ge K
Wei Sheng Yan Jiu; 2002 Jun; 31(3):193-6. PubMed ID: 12545760
[TBL] [Abstract][Full Text] [Related]
11. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
[TBL] [Abstract][Full Text] [Related]
12. Obesity and screening PSA levels among men undergoing an annual physical exam.
Rundle A; Neugut AI
Prostate; 2008 Mar; 68(4):373-80. PubMed ID: 18189231
[TBL] [Abstract][Full Text] [Related]
13. Central obesity as a risk factor for prostatic hyperplasia.
Lee S; Min HG; Choi SH; Kim YJ; Oh SW; Kim YJ; Park Y; Kim SS
Obesity (Silver Spring); 2006 Jan; 14(1):172-9. PubMed ID: 16493136
[TBL] [Abstract][Full Text] [Related]
14. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions.
Parsons JK; Sarma AV; McVary K; Wei JT
J Urol; 2009 Dec; 182(6 Suppl):S27-31. PubMed ID: 19846130
[TBL] [Abstract][Full Text] [Related]
15. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
[TBL] [Abstract][Full Text] [Related]
16. Obesity paradox in patients with hypertension and coronary artery disease.
Uretsky S; Messerli FH; Bangalore S; Champion A; Cooper-Dehoff RM; Zhou Q; Pepine CJ
Am J Med; 2007 Oct; 120(10):863-70. PubMed ID: 17904457
[TBL] [Abstract][Full Text] [Related]
17. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
Munkhaugen J; Lydersen S; Widerøe TE; Hallan S
Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474
[TBL] [Abstract][Full Text] [Related]
18. Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals.
Ingelsson E; Sullivan LM; Fox CS; Murabito JM; Benjamin EJ; Polak JF; Meigs JB; Keyes MJ; O'Donnell CJ; Wang TJ; D'Agostino RB; Wolf PA; Vasan RS
Circulation; 2007 Jul; 116(4):375-84. PubMed ID: 17620505
[TBL] [Abstract][Full Text] [Related]
19. Interaction between body mass index and alcohol intake in relation to blood pressure in HAN and SHE Chinese.
Li Y; Wang JG; Gao PJ; Wang GL; Qian YS; Zhu DL; Staessen JA
Am J Hypertens; 2006 May; 19(5):448-53. PubMed ID: 16647612
[TBL] [Abstract][Full Text] [Related]
20. Effect of BMI on primary treatment of prostate cancer.
Davies BJ; Walsh TJ; Ross PL; Knight SJ; Sadetsky N; Carroll PR; Kane CJ
Urology; 2008 Aug; 72(2):406-11. PubMed ID: 18267336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
